Neoadjuvant chemotherapy for locally advanced cervix cancer

Cochrane Database of Systematic Reviews

Volumn , Issue 4, 2009, Pages

  Tierney, Jayne F ^a   Benedetti Panici, Pierluigi ^b   Bermudez, Adriana ^c   Blake, Peter ^d   Cárdenas, Jesus ^e   Chang, Ting Chang ^f   Chiara, Silvana ^g   Di Paola, G ^c   Floquet, Anne ^h   Guthrie, David ^i,s   Kigawa, Junzo ^j   Kumar, Lalit ^k   Leborgne, Felix ^l   Lodge, Nick ^d   Poole, Chris ^m   Sardi, Juan ^a,c   Souhami, Luis ⁿ   Sundfør, Kolbein ^o   Symonds, Paul ^p   Tattersall, Martin ^q   Greggi, Stefano ^r   Vicky, Parker ^s   Parmar, Mahesh K B ^a   Stewart, Lesley A ^a   more..

^a MRC CLINICAL TRIALS UNIT   (United Kingdom)

^b UNIVERSITY CAMPUS BIO MEDICO   (Italy)

^c UNIVERSIDAD DE BUENOS AIRES   (Argentina)

^d ROYAL MARSDEN HOSPITAL   (United Kingdom)

^e Centro Estatal de Cancerologia   (Mexico)

^f CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^g UNIVERSITY OF GENOA   (Italy)

^h INSTITUT BERGONIÉ   (France)

ⁱ DERBYSHIRE ROYAL INFIRMARY   (United Kingdom)

^j TOTTORI UNIVERSITY   (Japan)

^k ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

^l Centro Hospitalario Pereira Rossell   (Uruguay)

^m CITY HOSPITAL   (United Kingdom)

ⁿ MONTREAL GENERAL HOSPITAL   (Canada)

^o OSLO UNIVERSITY HOSPITAL   (Norway)

^p LEICESTER ROYAL INFIRMARY   (United Kingdom)

^q UNIVERSITY OF SYDNEY   (Australia)

^r NATIONAL CANCER INSTITUTE   (Italy)

^s COU RAGE UK ^*  (United Kingdom)

more..

Author keywords

Adjuvant; Antineoplastic agents therapeutic use ; Chemotherapy; Cisplatin therapeutic use ; Female; Humans; Neoadjuvant therapy; Randomized controlled trials as topic; Survival analysis; Uterine cervical neoplasms *drug therapy; pathology

Indexed keywords

CISPLATIN;

ADVANCED CANCER; CANCER ADJUVANT THERAPY; CANCER PATIENT; CANCER STAGING; CANCER SURVIVAL; CLINICAL TRIAL; DISEASE FREE SURVIVAL; HUMAN; META ANALYSIS; MULTIPLE CYCLE TREATMENT; OVERALL SURVIVAL; REVIEW; RISK REDUCTION; SYSTEMATIC REVIEW; TREATMENT OUTCOME; UTERINE CERVIX CANCER;

EID: 77950179810     PISSN: 1469493X     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD001774.pub2     Document Type: Review

References (51)

1. Benedetti 2002 {published and unpublished data} * Benedetti-Panici P, Greggi S, Colombo A, Amoroso M, Smaniotto D, Gianarelli D, et al.Neoadjuvant chemotherapy and radical surgery versus exclusive radiotherapy in locally advanced cervical cancer: Results from the Italian multicenter randomised study. Journal of Clinical Oncology 2002;20(1):179-88.
2. Cardenas 1991 {published and unpublished data} * Cárdenas J, Olguín A, Figueroa F, Beccerra F, Huizar R. Randomized neoadjuvant chemotherapy in cervical carcinoma stage IIb. PEC+ RT vs RT. Proceedings of the American Society of Clinical Oncology 1991;10:189, A620.
3. Cardenas 1993 {published and unpublished data} * Cárdenas J, Olguín A, Figueroa F, Peña J, Beccerra F, Huizar R. A randomized trial of chemotherapy (CT) followed by radiotherapy (RT) vs radiotherapy alone in Stage IIIb cervical carcinoma: preliminary results. Fourth International Congress on Anti-Cancer Chemotherapy; 1993. 1993:87.
4. CCSG AOCOA 1995 {published and unpublished data} * Tattersall MHN, Lorvidhaya V, Vootiprux V, Cheirsilpa A,Wong F, Azhar T, et al.for the Cervical Cancer Study Group of the Asian Oceanian Clinical Oncology Association. Randomized trial of epirubicin and cisplatin chemotherapy followed by pelvic radiation in locally advanced cervical cancer. Journal of Clinical Oncology 1995;13(2):444-51.
5. Chang 2000 {published and unpublished data} * Chang T-C, Lai C-H, Hong J-H, Hsueh S, Huang K-G, Chou H-H, et al.Randomized trial of neaodjuvant cisplatin, vincristine, bleomycin, and radical hysterectomy versus radiation therapy for bulky stage Ib and IIA cervical cancer. Journal of Clinical Oncology 2000;18(8):1740-47.
6. Chauvergne 1993 {published and unpublished data} * Chauvergne J, Lhomme C, Rohart J, Heron JF, Ayme Y, Goupil A, et al.Neoadjuvant chemotherapy of stage IIb or III cancers of the uterine cervix. Long-term results of a multicenter randomized trial of 151 patients. [Chimiothérapie néoadjuvante des cancer du col utérin aux stades IIb e III. Résultats éloignés d'un essai randomisé pluricentrique portant sur 151 patients]. Bulletin du Cancer 1993;80: 1069-79.
7. Chiara 1994 {published and unpublished data} * Chiara S, Bruzzone M, Merlini L, Bruzzi P, Rosso R, Franzone P, et al.Randomized study comparing chemotherapy plus radiotherapy versus radiotherapy alone in FIGO stage IIB-III cervical carcinoma. American Journal of Clinical Oncology 1994;17(4):294-7.
8. Herod 2000 {published and unpublished data} * Herod J, Burton A, Bixton J, Tobias J, Luesley D, Jordan S, et al.A randomised prospective phase III clinical trial of primary bleomycin, ifosfamide and cisplatin (BIP) chemotherapy followed by radiotherapy versus radiotherapy alone in operable cancer of the cervix. Annals of Oncology 2000;11:1175-81.
9. Kigawa 1996 {published and unpublished data} * Kigawa J, Minagawa Y, Ishihara H, Itamochi H, Kanamori Y, Terawaka N. The role of neoadjuvant intra-arterial infusion chemotherapy with cisplatin and bleomycin for locally advanced cervical cancer. American Journal of Clinical Oncology 1996;19(3): 255-9.
10. Kumar 1998a {published and unpublished data} * Kumar L, Grover R, Pokharel YH, Chander S, Kumar S, Singh R, et al.Neoadjuvant chemotherapy in locally advanced cervical cancer: two randomised studies. Australian and New Zealand Journal of Medicine 1998;28:387-90.
11. Leborgne 1997 {published and unpublished data} * Leborgne F, Leborgne JH, Doldán R, Zubizarreta E, Ortega B, Maisonneuve J, et al.Induction chemotherapy and radiotherapy of advanced cancer of the cervix: a pilot study and phase III randomized trial. International Journal of Radiation Oncology, Biology, Physics 1997;37(2):343-50.
12. LGOG {unpublished data only} * LGOG. Neo-adjuvant chemotherapy in locally advanced carcinoma of the cervix. Unpublished.
13. MRC CeCa {unpublished data only} * Medical Research Council. A study of potentially curative therapy alone or preceded by chemotherapy in the treatment of Stage Ib-IVa cervical carcinoma. Unpublished.
14. PMB {unpublished data only} * PMB Group. Neo-adjuvant chemotherapy in locally advanced carcinoma of the cervix. Unpublished.
15. Sardi 1996 {published and unpublished data} * Sardi J, Giaroli A, Sananes C, Rueda NG, Vighi S, Ferreira M, et al.Randomized trial with neoadjuvant chemotherapy in stage IIIB squamous carcinoma cervix uteri: an unexpected therapeutic management. International Journal of Gynecological Cancer 1996;6: 85-93.
16. Sardi 1997 {published and unpublished data} * Sardi JE, Giaroli A, Sananes C, Ferreira M, Soderini A, Bermudez A, et al.Long-term follow-up of the first randomized trial using neoadjuvant chemotherapy in Stage Ib squamous carcinoma of the cervix. The final results. 1997. Gynecologic Oncology 1997;67:61-9.
17. Sardi 1998 {published and unpublished data} * Sardi JE, Sananes CE, Giaroli AA, Bermudez A, Ferreira M, Soderini AH, et al.Neoadjuvant chemotherapy in cervical carcinoma stage IIB: a randomized controlled trial. International Journal of Gynecological Cancer 1998;8:441-50.
18. Souhami 1991 {published and unpublished data} * Souhami L, Gil RA, Allan SE, Canary PC, Araujo CM, Pinto LH, et al.A randomized trial of chemotherapy followed by pelvic radiation therapy in Stage IIIB carcinoma of the cervix. Journal of Clinical Oncology 1991;9(6):970-7.
19. Sundfor 1996 {published and unpublished data} * Sundfor K, Tropé CG, Högberg T, Onsrud M, Koern J, Simonsen E, et al.Radiotherapy and neoadjuvant chemotherapy for cervical carcinoma. A randomized multicenter study of sequential cisplatin and 5-fluoracil and radiotherapy in advanced cervical carcinoma Stage 3B and 4A. Cancer 1996;77:2371-8.
20. Symonds 2000 {published and unpublished data} * Symonds RP, Habeshaw T, Reed NS, Paul J, Pyper E, Yosef H, et al.The Scottish and Manchester randomised trial of neo-adjuvant chemotherapy for advanced cervical cancer. European Journal of Cancer 2000;36:994- 1001.
21. Tattersall 1992 {published and unpublished data} * Tattersall MHN, Ramirez C, Coppleson M. A randomized trial comparing platinum-based chemotherapy followed by radiotherapy alone in patients with locally advanced cervical cancer. International Journal of Gynecological Cancer 1992;2:244-51.
22. FNCLCC COII {unpublished data only} * Groupe cooeperateur de gynecologie de la FNCLCC. Phase III randomized study of radiotherapy with vs without BLEO/MITO/CDDP/VP-16 for locally advanced squamous cell carcinoma of the cervix. Unpublished.
23. GOG 141 {unpublished data only} * GOG 141. Phase III study in the treatment of bulky Stage IB carcinoma of the cervix: neoadjuvant CDDP/VCR vs no neoadjuvant therapy followed by radical hysterectomy and pelvic/para-aortic node dissection. Unpublished neoadjuvant CDDP/VCR vs no neoadjuvant therapy followed by radical hysterectomy and pelvic/para-aortic node dissection. Unpublished.
24. Kumar 1998b {published data only} * Kumar L, Grover R, Pokharel YH, Chander S, Kumar S, Singh R, et al.Neoadjuvant chemotherapy in locally advanced cervical cancer: two randomised studies. Australian and New Zealand Journal of Medicine 1998;28:387-90.
25. Lira Puerto 1990 {published data only} * Lira Puerto V, De la Huerta R, Cortes H, et al.Ciplatin (CDDP) plus radiotherapy (RT) vs radiotherapy alone in locally advanced cervical cancer. Proceedings of the Annual Meeting of the American Society of Clinical Oncology 1990;9:abstract 633.
26. Lorvidhaya 1995 {published data only} * Lorvidhaya V, Tonusin A, Sukthomya W, Changwiwit W, Nimmolrat A. Induction chemotherapy and irradiation in advanced carcinoma of the cervix. Gan To Kagaku Ryoho 1995;22 Suppl 3: 244-51.
27. Mickiewicz 1996 {published data only} * Mickiewicz E, Porcella H, Roth B, et al.Do patients with locally advanced cervical carcinoma responding to adjuvant chemotherapy benefit from a surgical approach? Preliminary report of a prospective randomised trial. Proceedings of the Annual Meeting of the American Society of Clinical Oncology 1996;15:abstract 823.
28. Napolitano 2003 {published data only} * Napolitano U, Imperato F, Mossa B, Framarino ML, Marziani R, Marzetti L. The role of neoadjuvant chemotherapy for squamous cell cervical cancer (Ib-IIIb): a long-term randomized trial. European Journal of Gynaecological Oncology 2003;24(1):51-9.
29. Park 1996 {published and unpublished data} * Park SY, Kim JH, Kim BG, et al.Phase III randomized study of MVC intraarterial (arm 1), or systemic (arm 2) neoadjuvant chemotherapy versus radiation therapy only (arm3) for stage IIb bulky carcinoma of uterine cervix: preliminary report. Proceedings of the Annual Meeting of the American Society of Clinical Oncology 1996;15:302, abstract 840.
30. Tabata 2003 {published data only} * Tabata T, Takeshima N, Nishida H, Hirai Y, Hasumi K. A randomized study of primary bleomycin, vincristine, mitomycin and cisplatin (BOMP) chemotherapy followed by radiotherapy versus radiotherapy alone in stage IIIB and IVA squamous cell carcinoma of the cervix. Anticancer Research 2003;23(3C): 2885-90.
31. WGH {unpublished data only} * Western General Hospital Edinburgh. Treatment of advanced FIGO stage IIB or IIIB carcinoma of the cervix. Unpublished.
32. ABCOC 1995 Advanced Bladder Cancer Overview Collaboration. Does neoadjuvant cisplatin-based chemotherapy improve the survival of patients with locally advanced bladder cancer: a meta-analysis of individual patient data from randomised clinical trials. British Journal of Urology 1995;75:206-13.
33. Benedet 1998 Benedet J, Odicino F, Maisonneuve P, et al.Carcinoma of the cervix uteri. Journal of Epidemiology and Biostatistics 1998;3:5-34.
34. Bolger 1996 Bolger BS, Symonds RP, Stanton PD, MacLean AB, Burnett R, Kelly P, et al.Prediction of radiotherapy response of cervical carcinoma through measurement of proliferation rate. British Journal of Cancer 1996;74:1223-6.
35. Dickersin 1995 Dickersin K, Scherer R, Lefebvre C. Identifying relevant studies for systematic reviews. In: Chalmers I, Altman DG editor(s). Systematic Reviews. London: BMJ Publishing Group, 1995:17-36.
36. Eifel 1995 Eifel PJ, Thames HD. Has the influence of treatment duration on local control of carcinoma of the cervix been defined?. International Journal of Radiation Oncology, Biology, Physics 1995;32(5):1527-9.
37. Eifel 2001 Eifel PJ, Berek JS, Thigpen JT. Gynecologic Cancers. Section 2. Cancer of the cervix, vagina, vulva. In: DeVita VT, Jr, Hellman S, Rosenberg SA editor(s). Cancer: Principles & Practice of Oncology. 6th Edition. Vol. 2, Philadelphia: Lippincott-Raven, 2001: 1526-56.
38. Green 2001 Green JA, Kirwan JM, Tierney JF, Symonds P, Fresco L, Collingwood M, et al.Survival and recurrence after concomitant cehmotherapy and radiotherapy for cancer of the uterine cervix: a systematic review and meta-analysis. Lancet 2001;358:781-6.
39. Kaplan 1958 Kaplan EL, Meier P. Nonparametric estimation from incomplete observation. Journal of the American Statistical Association 1958;53: 457-81.
40. Parkin 1993 Parkin DM, Pisani P, Ferlay J. Estimates of the worldwide incidence of eighteen major cancers in 1985. International Journal of Cancer 1993;54:594-606.
41. Parmar 1995 Parmar MKB, Machin D. Survival analysis: a practical approach. John Wiley & Sons Ltd, 1995.
42. Perez 1995 Perez CA, Grigsby PW, Castro-Vita H, Lockett MA. Carcinoma of the cervix. I. Impact of prolongation of overall treatment time and timing of brachytherapy on the outcome of radiation therapy. International Journal of Radiation Oncology Biology Physics 1995;32 (5):1275-88.
43. Petereit 1995 Petereit DG, Sarkaria JN, Chappell R, Fowler JF, Hartmann TJ, Kinsella, et al.The adverse effect of treatment prolongation in cervical carcinoma. International Journal of Radiation Oncology, Biology, Physics 1995;32(5):1301-7.
44. Pignon 2000 Pignon JP, Bourhis J, Domenge C, Designé L, on behalf of the MACH-NC Collaborative Group. Chemotherapy added to locoregional treatment for head and neck squamous cell carcinoma: three meta-analyses of updated individual data. Lancet 2000;355: 949-55.
45. Rew 2000 Rew DA, Wilson GD. Cell production rates in human tissues and tumours and their significance. Part II: clinical data. European Journal of Surgical Oncology 2000;26:405-417.
46. Rose 2002 Rose PG. Chemoradiotherapy for cervical cancer. European Journal of Cancer 2002;38:270-8.
47. Stewart 1993 Stewart LA, Parmar MKB. Meta-analysis of the literature or of individual patient data: is there a difference?. Lancet 1993;341: 418-22.
48. Stewart 1995 Stewart LA, Clarke MJ, on behalf of the Cochrane Working Party Group on Meta-analysis using Individual Patient Data. Practical methodology of meta-analyses (overviews) using updated individual patient data. Statistics in Medicine 1995;14:2057-79.
49. Tierney 1999 Tierney JF, Stewart LA, Parmar MKB. Can the published data tell us about the effectiveness of neoadjuvant chemotherapy for locally advanced cancer of the uterine cervix?. European Journal of Cancer 1999;35(3):406-9.
50. Yusuf 1985 Yusuf S, Peto R, Lewis J, Collins R, Sleight P. Beta-blockade during and after myocardial infarction: An overview of the randomised trials. Progress in Cardiovascular Diseases 1985;27(5):335-71.
51. NACCCMA 2003 Neoadjuvant Chemotherapy for Cervical Cancer Meta-analysis Collaboration. Neoadjuvant chemotherapy for locally advanced cervical cancer: a systematic review and meta-analysis of individual patient data from 21 randomised trials. European Journal of Cancer 2003;39(17):2470-86.